Dados B3 › GGBR4 × CMIN3
GGBR4 × CMIN3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | GGBR4 | CMIN3 | year |
|---|---|---|---|
| ROE | 2.5% | 19.5% | 2025 |
| ROIC | 3.4% | 55.4% | 2025 |
| ROA | 1.7% | 4.7% | 2025 |
| Gross margin | 11.4% | 45.4% | 2025 |
| EBIT margin | 5.4% | 27.8% | 2025 |
| Net margin | 2.0% | 9.1% | 2025 |
| Net debt/EBITDA | 1.05x | 0.05x | 2025 |
| Current ratio | 2.89x | 1.20x | 2025 |
| Revenue growth (1y) | 4.2% | 9.3% | 2025 |
| Revenue growth (5y CAGR) | 9.8% | 5.5% | 2025 |
| Piotroski F-Score | 5/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | GGBR4 | CMIN3 | year |
|---|---|---|---|
| P/E | 30.77x | — | 2025 × 2024 |
| P/B | 0.80x | 3.23x | 2025 × 2024 |
| EV/EBITDA | 6.80x | 4.60x | 2025 × 2024 |
| FCF yield | 2.7% | 30.1% | 2025 × 2024 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 12:04 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 12:04 UTC. If this does not match /saude, you are reading a cached copy.